Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PATTI, Angelo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.906
EU - Europa 3.058
AS - Asia 2.103
SA - Sud America 392
AF - Africa 67
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.854
IT - Italia 1.195
SG - Singapore 846
CN - Cina 605
RU - Federazione Russa 357
FI - Finlandia 342
BR - Brasile 318
DE - Germania 297
HK - Hong Kong 216
PL - Polonia 196
UA - Ucraina 146
GB - Regno Unito 138
VN - Vietnam 137
IE - Irlanda 100
SE - Svezia 63
IN - India 61
FR - Francia 60
RO - Romania 34
AT - Austria 27
IR - Iran 27
CA - Canada 24
TR - Turchia 24
AR - Argentina 23
KR - Corea 23
BD - Bangladesh 22
BE - Belgio 22
IQ - Iraq 21
CI - Costa d'Avorio 20
MX - Messico 20
ES - Italia 18
ZA - Sudafrica 15
AU - Australia 14
UZ - Uzbekistan 14
JP - Giappone 13
TH - Thailandia 13
PK - Pakistan 12
NL - Olanda 11
MY - Malesia 10
CH - Svizzera 9
CO - Colombia 9
EC - Ecuador 8
GR - Grecia 8
ID - Indonesia 8
IL - Israele 8
SA - Arabia Saudita 8
CL - Cile 7
MA - Marocco 7
BG - Bulgaria 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
KE - Kenya 6
PH - Filippine 6
PY - Paraguay 6
VE - Venezuela 6
DK - Danimarca 5
NP - Nepal 5
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
LT - Lituania 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
JO - Giordania 3
LB - Libano 3
PE - Perù 3
TW - Taiwan 3
AL - Albania 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
JM - Giamaica 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
RE - Reunion 1
RS - Serbia 1
SM - San Marino 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 10.547
Salva come PNG Salva come JPEG
Città #
Ashburn 617
Singapore 576
Fairfield 556
Chandler 406
Wilmington 255
Woodbridge 251
Seattle 220
Houston 219
Hong Kong 204
Cambridge 184
Ann Arbor 164
Zgierz 163
Palermo 136
Moscow 114
Beijing 108
Medford 108
Des Moines 104
Rome 102
Dublin 99
Los Angeles 84
San Jose 78
Jacksonville 77
New York 71
Princeton 68
Altamura 67
Dallas 67
Nanjing 67
Milan 64
Lawrence 51
Santa Clara 47
Helsinki 46
Council Bluffs 41
Ho Chi Minh City 37
San Diego 37
The Dalles 35
São Paulo 34
Boardman 33
Hefei 33
Hanoi 30
Jinan 30
Buffalo 29
Tulsa 26
Changsha 25
Dearborn 25
London 24
Nuremberg 24
Shenyang 24
Chicago 23
Warsaw 23
Nanchang 22
Abidjan 20
Tianjin 20
Brussels 19
Hebei 19
Redwood City 18
Guangzhou 17
Munich 17
Ningbo 17
Florence 16
Ludwigshafen am Rhein 16
Tehran 16
Poplar 14
Rio de Janeiro 14
Baghdad 13
Bangkok 13
Boston 13
Chennai 13
Da Nang 13
Denver 13
Columbus 12
Jiaxing 12
Johannesburg 12
Naples 12
Phoenix 12
Verona 12
Bari 11
Napoli 11
Orem 11
San Paolo di Civitate 11
Tokyo 11
Catania 10
Falls Church 10
Melbourne 10
Stockholm 10
Amsterdam 9
Atlanta 9
Cagliari 9
Kumar 9
Montreal 9
Pisa 9
Seongnam 9
Venice 9
Bangalore 8
Belo Horizonte 8
Edinburgh 8
Frankfurt am Main 8
Guidizzolo 8
Lappeenranta 8
Saint Petersburg 8
Vienna 8
Totale 6.532
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 794
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 257
Autoimmune liver disease in a sicilian woman. 221
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 220
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 215
The Role of Nutraceuticals in Statin Intolerant Patients 207
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 198
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE 196
Management of Statin Intolerance in 2018: Still More Questions Than Answers 195
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 193
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 188
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 183
Osteodystrophy in chronic liver diseases. 180
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 179
The effect of bergamot on dyslipidemia 178
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 177
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici 174
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 166
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 165
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 165
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 164
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 162
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. 161
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 159
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia 158
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? 152
O- Alkylation of a lignite humic acid by phase-transfer catalysis 152
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE 149
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 141
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 139
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 138
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. 137
Malignant tumor-like gastric lesion by Candida albicans. 136
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 134
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. 133
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. 130
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 130
Nutraceuticals as an important part of combination therapy in dyslipidaemia 129
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 128
Advances in pharmacological treatment of type 1 diabetes during pregnancy 128
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 127
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. 125
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 125
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 122
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 121
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats 120
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. 119
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 118
Anti-atherogenic Effects of 17β-Estradiol 118
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 118
Smoking and small, dense low-density lipoproteins. 115
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica 113
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 112
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 110
Natural approaches in metabolic syndrome management 103
Metabolic disorders during pregnancy and postpartum cardiometabolic risk 102
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS 100
Future perspectives of the pharmacological management of diabetic dyslipidemia 97
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 96
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 91
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 84
Pharmacotherapy for gestational diabetes 84
Novel therapeutical approaches to managing atherosclerotic risk 84
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 83
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 82
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 78
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 75
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 70
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 69
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 66
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives 66
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies 65
NUOVE STRATEGIE PER IL MANAGEMENT CLINICO, DIAGNOSTICO E TERAPEUTICO DELLE MALATTIE CARDIO-METABOLICHE 65
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 55
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 51
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 51
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 49
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 43
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 43
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 40
Obesity and HFpEF 40
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? 38
Impact of different hormones on the regulation of nitric oxide in diabetes 34
Totale 10.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 0 62 90 109 130 68 87
2021/2022881 51 136 40 32 23 38 35 76 92 140 66 152
2022/20231.411 135 211 30 135 126 191 126 120 151 37 91 58
2023/2024681 35 91 53 43 44 143 85 37 20 18 34 78
2024/20251.558 29 172 113 143 67 55 116 80 116 168 183 316
2025/20262.616 344 158 252 456 548 694 164 0 0 0 0 0
Totale 10.978